Вісник проблем біології і медицини -2024 -Вип. 2 (173) / Bulletin of problems in biology and medicine -2024 -Issue 2 (173)
253
КЛІНІЧНА ТА ЕКСПЕРИМЕНТАЛЬНА МЕДИЦИНА / CLINICAL AND EXPERIMENTAL MEDICINETaking into account the above data, the patient was diagnosed with the following: Limb-girdle muscular dystrophy, type 2A (calpainopathy) with peripheral proximal tetraparesis (mild in the arms, moderate in the legs), myopathic syndrome, moderate impairment of walking function.The patient underwent neurometabolic, antioxidant, general strengthening therapy, vitamin therapy and physiotherapy.Conclusions. To date, there is no specific treatment for calpainopathy, therefore, therapy is symptomatic, aimed at normalizing the patient's general condition, restoring lost functions and possibly slowing the rate of progression. Dynamic monitoring of the patient and timely management of symptoms improves the possibility of extending life expectancy and improving its quality.